SONOSCAPE(SZ:300633) Sou Hu Cai Jing·2026-02-02 13:05Group 1 - The core viewpoint of the article highlights the recent performance and financial metrics of Kaili Medical (300633), indicating a decline in stock price and mixed financial results [1][2]. - As of February 2, 2026, Kaili Medical's stock closed at 27.16 yuan, down 2.13%, with a trading volume of 37,100 hands and a total transaction amount of 102 million yuan [1]. - The company's main business involves the independent research, production, and sales of medical diagnostic and treatment equipment [2]. Group 2 - In the third quarter of 2025, Kaili Medical reported a main revenue of 1.459 billion yuan, a year-on-year increase of 4.37%, while the net profit attributable to shareholders decreased by 69.25% to 33.51 million yuan [2]. - The third quarter also saw a single-quarter main revenue of 495 million yuan, reflecting a year-on-year increase of 28.42%, but a net profit of -13.52 million yuan, which is an increase of 78.05% compared to the previous year [2]. - The company has a debt ratio of 24.22%, with an investment income of 2.08 million yuan and financial expenses of -38.30 million yuan, while maintaining a gross profit margin of 60.36% [2]. Group 3 - Over the last 90 days, five institutions have provided ratings for Kaili Medical, with four buy ratings and one hold rating [3]. - The article explains the concept of fund flow, indicating that the net flow of funds is determined by the difference between buying and selling pressures in the market [3].